Series C funding round for Enveda Biosciences raising $130M in November 2024
Series C funding round for Enveda Biosciences raising $130M in November 2024
| Investor | Firm Type | Partner |
|---|
FPV VenturesLEAD | Venture Capital | — |
KinnevikLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Non Profit | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Henry Kravis |
| Angel | rajiv chegu |
| Angel | Chris Gibson |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$592M
Top Valuation
-
Enveda Biosciences raised $130M in a Series C round.
The round was announced on 11/01/24.
The round was led by Kinnevik, Pegah Ebrahimi.